LNCAROD

Across TCGA pan-cancer cohorts, LNCAROD RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of LNCAROD’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where LNCAROD RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LNCAROD is over-expressed in tumor.

HNSC, LUAD, and LIHC are the cancer types where LNCAROD tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LNCAROD RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	III,IV	+2.145	<.001	11	view →
LUAD	All	All	+0.557	<.001	7	view →
LIHC	Male	All	+0.134	<.001	6	view →
LUSC	All	II,III,IV	+1.259	<.001	5	view →
BLCA	All	IV	+0.162	.022	5	view →
KIRC	Male	All	+0.079	<.001	5	view →
BRCA	Female	All	+0.250	.003	4	view →
PAAD	Female	All	+0.355	.049	2	view →
KIRP	All	All	+0.079	.006	2	view →
THCA	All	II,III,IV	+0.030	.020	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

LNCAROD–HNSC

Open the HNSC breakdown →